EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access

Thrombocytopenia as a Bleeding Risk Factor in Atrial Fibrillation and Coronary Artery Disease: Insights From the AFIRE Study

Raisuke Iijima iD, Masahide Tokue iD, Masato Nakamura iD, Satoshi Yasuda, Koichi Kaikita iD, Masaharu Akao iD, Junya Ako iD, Tetsuya Matoba iD, Katsumi Miyauchi iD, Nobuhisa Hagiwara, Kazuo Kimura iD, Atsushi Hirayama iD und 3 weitere

Journal of the American Heart Association · 2023

DOI: 10.1161/jaha.123.031096 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of the American Heart Association, 2023. Verfasst von Raisuke Iijima und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine Toho University Ohashi Medical Center Tokyo Japan. Hauptthemen laut MEDLINE: Atrial Fibrillation, Coronary Artery Disease, Percutaneous Coronary Intervention, Thrombocytopenia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Thrombocytopenia poses a risk of bleeding in patients with chronic coronary syndrome after coronary intervention. However, whether thrombocytopenia also increases the bleeding risk in patients with atrial fibrillation and chronic coronary syndrome remains unclear. Methods and Results This study evaluated the AFIRE (Atrial Fibrillation and Ischemic Events With Rivaroxaban in Patients With Stable Coronary Artery Disease) trial. Thrombocytopenia was defined as platelet count

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCoronary Artery DiseasePercutaneous Coronary InterventionThrombocytopeniaHumansAnticoagulantsHemorrhagePlatelet Aggregation InhibitorsRisk FactorsRivaroxabanTreatment Outcome

Stichwörter der Autor:innen

atrial fibrillationchronic coronary syndromethrombocytopenia

Substanzen

AnticoagulantsPlatelet Aggregation InhibitorsRivaroxaban

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine Toho University Ohashi Medical Center Tokyo Japan.
  • Kawasaki Miyamaedaira Tokue Internal-Cardiovascular Medical Clinic Kawasaki Japan.
  • Department of Cardiovascular Medicine Tohoku University Graduate School of Medicine Sendai Japan.
  • Division of Cardiovascular Medicine and Nephrology, Department of Internal Medicine, Faculty of Medicine University of Miyazaki Miyazaki Japan.
  • Department of Cardiology National Hospital Organization Kyoto Medical Center Kyoto Japan.
  • Department of Cardiovascular Medicine Kitasato University School of Medicine Sagamihara Japan.

ORCID-Profile: Raisuke Iijima, Masahide Tokue, Masato Nakamura, Koichi Kaikita, Masaharu Akao, Junya Ako, Tetsuya Matoba, Katsumi Miyauchi, Kazuo Kimura, Atsushi Hirayama, Kunihiko Matsui, Hisao Ogawa

Zitieren

APA

Iijima, R., Tokue, M., Nakamura, M., Yasuda, S., Kaikita, K., Akao, M., Ako, J., Matoba, T., Miyauchi, K., Hagiwara, N., Kimura, K., Hirayama, A., Matsui, K., Ogawa, H., & AFIRE Investigators (2023). Thrombocytopenia as a Bleeding Risk Factor in Atrial Fibrillation and Coronary Artery Disease: Insights From the AFIRE Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.031096

Vancouver

Iijima R, Tokue M, Nakamura M, Yasuda S, Kaikita K, Akao M, et al. Thrombocytopenia as a Bleeding Risk Factor in Atrial Fibrillation and Coronary Artery Disease: Insights From the AFIRE Study. Journal of the American Heart Association. 2023. doi:10.1161/jaha.123.031096

BibTeX
@article{Iijima2023,
  author = {Iijima, Raisuke and Tokue, Masahide and Nakamura, Masato and Yasuda, Satoshi and Kaikita, Koichi and Akao, Masaharu and Ako, Junya and Matoba, Tetsuya and Miyauchi, Katsumi and Hagiwara, Nobuhisa and Kimura, Kazuo and Hirayama, Atsushi and Matsui, Kunihiko and Ogawa, Hisao and AFIRE Investigators, AFIRE Investigators},
  title = {Thrombocytopenia as a Bleeding Risk Factor in Atrial Fibrillation and Coronary Artery Disease: Insights From the AFIRE Study},
  journal = {Journal of the American Heart Association},
  year = {2023},
  doi = {10.1161/jaha.123.031096}
}
Kostenlos starten →